CEMIP and colorectal carcinoma: Moreover, CEMIP, an oncogene, downregulates MHC‐I on CRC cell surfaces by acting as an adaptor that facilitates MHC‐I's clathrin‐dependent endocytosis, leading to its lysosomal degradation.